Brean Capital Weighs In On Keryx Biopharmaceuticals Inc. And Rockwell Medical Inc. In Light Of Dialysis Drugs
June 23, 2015 at 13:47 PM EDT
On June 22, Brean Capital analyst Jonathan Aschoff weighed in on Keryx Biopharmaceuticals Inc. and Rockwell Medical Inc. to provide commentary on both companies’ dialysis drugs.
